The U.S. International Trade Commission voted unanimously on July 11, 2025, to find a reasonable indication that a U.S. industry is materially injured by imports of l-lysine from China, which are alleged to be sold in the United States at less than fair value and subsidized by the Chinese government. The affirmative determination by Chair Amy A. Karpel and Commissioners David S. Johanson and Jason E. Kearns triggers continuation of the Commerce Department’s antidumping and countervailing duty investigations into Chinese lysine imports.
What it means
Because the USITC reached affirmative preliminary determinations, the U.S. Department of Commerce will proceed with both investigations rather than terminate them. Commerce is due to issue its preliminary countervailing duty determination on or about August 21, 2025, and its preliminary antidumping duty determination on or about November 4, 2025.
Key facts
- USITC determination date: July 11, 2025
- Countervailing duty investigation: Inv. No. 701-TA-767
- Antidumping duty investigation: Inv. No. 731-TA-1750
- Preliminary CVD determination due from Commerce: on or about August 21, 2025
- Preliminary antidumping determination due from Commerce: on or about November 4, 2025
- Commission public report: USITC Publication 5650, to be available by August 18, 2025
- Vote: Chair Amy A. Karpel, Commissioner David S. Johanson, Commissioner Jason E. Kearns — all affirmative
Source: U.S. International Trade Commission news release (usitc.gov)